Addus HomeCare Corporation (ADUS)
Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates
Addus HomeCare (ADUS) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.35 per share a year ago.
ADUS vs. USPH: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks presents investors with the better value opportunity right now?
Addus HomeCare Corporation (ADUS) Q1 2025 Earnings Call Transcript
Addus HomeCare Corporation (NASDAQ:ADUS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Dru Anderson - Senior Partner-FINN Partners Dirk Allison - Chairman & Chief Executive Officer Brian Poff - Chief Financial Officer Brad Bickham - President & Chief Operating Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Joanna Gajuk - Bank of America Tao Qiu - Macquarie Jared Haase - William Blair Matthew Gillmor - KeyBanc Meghan Holtz - Jefferies Constantine Davides - Citizens Bank Ryan Langston - TD Cowen John Ransom - Raymond James Operator Good day, and welcome to the Addus HomeCare First Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode.
Addus HomeCare (ADUS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Addus HomeCare (ADUS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Addus HomeCare (ADUS) Beats Q1 Earnings Estimates
Addus HomeCare (ADUS) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.21 per share a year ago.
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?
Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?
Addus HomeCare (ADUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Addus HomeCare (ADUS) Surges 4.9%: Is This an Indication of Further Gains?
Addus HomeCare (ADUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?
Addus HomeCare (ADUS) Upgraded to Strong Buy: Here's Why
Addus HomeCare (ADUS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ADUS vs. USPH: Which Stock Is the Better Value Option?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?
Are Investors Undervaluing Addus HomeCare (ADUS) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
